Background: Cell free circulating DNA (cfcDNA) is a promising diagnostic tool for prostate cancer (PCa). This study aimed to measure the cfcDNA concentration and integrity in PCa patients using quantitative polymerase chain reaction (qPCR) analysis. This study also assessed the correlation between these molecular biomarkers with total prostate-specific antigen (PSA), Gleason score, prostate volume, and age.
Methods: Eleven PCa patients and 9 persons with benign prostatic hyperplasia (BPH) were recruited. Blood samples were collected before prostate biopsy and plasma quantified by qPCR amplification of the ALU 115 DNA sequence, with the ratio of ALU 247 to ALU 115 reflecting cfcDNA integrity.
Results: There were no significant differences in median, interquartile range (IQR) cfcDNA concentration or cfcDNA integrity between the patients with PCa (47.9 (214.93) ng/mL; 0.61 (0.49)) and persons with BPH (41.5 (55.13) ng/mL, = 0.382; 0.67 (0.45), = 0.342). A weakly positive correlation exists between cfcDNA concentration and total PSA (r = 0.200, = 0.555) but not with age or Gleason score in PCa patients.
Conclusion: cfcDNA concentration was relatively nonsignificantly higher in PCa patients in comparison to persons with BPH, whereas cfcDNA integrity was similar in both groups. Though limited in sample size, this study shows that cfcDNA concentration may be a potentially valuable noninvasive biomarker for the diagnosis of PCa.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564624 | PMC |
| http://dx.doi.org/10.3390/diseases8030034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study.
Diseases
September 2020
Department of Basic Medical Sciences (Pharmacology Section), Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica.
Background: Cell free circulating DNA (cfcDNA) is a promising diagnostic tool for prostate cancer (PCa). This study aimed to measure the cfcDNA concentration and integrity in PCa patients using quantitative polymerase chain reaction (qPCR) analysis. This study also assessed the correlation between these molecular biomarkers with total prostate-specific antigen (PSA), Gleason score, prostate volume, and age.
View Article and Find Full Text PDFApplication of the Z-scan technique for the detection of CFCDNA (cell-free circulating DNA) and urine DNA (uDNA) in patients with bladder cancer.
Photodiagnosis Photodyn Ther
June 2019
Laboratório de Análises Clínicas da Faculdade de Medicine do ABC, Av. Lauro Gomes, 2000, CEP 09060-870, Santo André, SP, Brazil; Departamento de Ciências Farmacêuticas da Universidade Federal de São Paulo, Rua São Nicolau, 210, CEP 09913-030, Diadema, SP, Brazil. Electronic address:
Background: Patients with BC have a higher amount of cell-free circulating DNA (CFCDNA) in the blood and urine than healthy people. We aimed to verify if the Z-Scan method could analyze the concentrations of uDNA (urinary) and pDNA (plasma) in relation to the time of collection during treatment for patients with bladder cancer.
Methods: Peripheral blood and urine samples were obtained from 30 patients with BC at the time of diagnosis, 45, 90 and 180 days after initiating treatment; 5 μL of k-DNA (k = u or p) was added in 250 μL a solution of 1:1000 Ethidium Bromide dye (EtBr) in water.
Dielectrophoretic isolation and detection of cfc-DNA nanoparticulate biomarkers and virus from blood.
Electrophoresis
April 2013
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Dielectrophoretic (DEP) microarray devices allow important cellular nanoparticulate biomarkers and virus to be rapidly isolated, concentrated, and detected directly from clinical and biological samples. A variety of submicron nanoparticulate entities including cell free circulating (cfc) DNA, mitochondria, and virus can be isolated into DEP high-field areas on microelectrodes, while blood cells and other micron-size entities become isolated into DEP low-field areas between the microelectrodes. The nanoparticulate entities are held in the DEP high-field areas while cells are washed away along with proteins and other small molecules that are not affected by the DEP electric fields.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!